Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Therapeutic Index01:13

Therapeutic Index

6.8K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.8K
Therapeutic Communication01:30

Therapeutic Communication

8.0K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.0K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

1.5K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.1K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.1K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

1.9K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.9K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

958
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
958

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transforming Preeclampsia Care: Molecular Diagnostics and Therapeutic Innovations.

Journal of the American Society of Nephrology : JASN·2026
Same author

Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial.

Nature medicine·2026
Same author

Butyrophilin 2A2 promotes T cell immunoregulation via CD45 phosphatase activation and protects against murine autoimmune glomerulonephritis and pregnancy loss.

Nature communications·2026
Same author

Pointing Care for Preeclampsia in the Right Direction.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Serum soluble-fms-like tyrosine kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancy.

American journal of obstetrics and gynecology·2025
Same author

Lipid-delivery system could treat life-threatening pregnancy complication.

Nature·2024

Related Experiment Video

Updated: Jan 31, 2026

Construction of an Affordable and Easy-to-Build Zebrafish Facility
12:19

Construction of an Affordable and Easy-to-Build Zebrafish Facility

Published on: November 22, 2014

17.1K

Affordable Preeclampsia Therapeutics.

Elizabeth Lemoine1, Ravi Thadhani1

  • 1Harvard Medical School, Boston, MA, USA; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Trends in Pharmacological Sciences
|January 6, 2019
PubMed
Summary
This summary is machine-generated.

Preeclampsia treatment is limited, but RNAi successfully reduced a key protein in baboons. This offers hope for new therapies, especially in underserved regions.

Keywords:
RNAihypertensive disorders of pregnancypreeclampsiapreeclampsia therapeuticssFLT1siRNA

More Related Videos

Simple, Affordable, and Modular Patterning of Cells using DNA
08:59

Simple, Affordable, and Modular Patterning of Cells using DNA

Published on: February 24, 2021

4.7K
Using Affordable LED Arrays for Photo-Stimulation of Neurons
07:40

Using Affordable LED Arrays for Photo-Stimulation of Neurons

Published on: November 15, 2011

19.1K

Related Experiment Videos

Last Updated: Jan 31, 2026

Construction of an Affordable and Easy-to-Build Zebrafish Facility
12:19

Construction of an Affordable and Easy-to-Build Zebrafish Facility

Published on: November 22, 2014

17.1K
Simple, Affordable, and Modular Patterning of Cells using DNA
08:59

Simple, Affordable, and Modular Patterning of Cells using DNA

Published on: February 24, 2021

4.7K
Using Affordable LED Arrays for Photo-Stimulation of Neurons
07:40

Using Affordable LED Arrays for Photo-Stimulation of Neurons

Published on: November 15, 2011

19.1K

Area of Science:

  • Reproductive medicine
  • Molecular medicine
  • Genetics

Background:

  • Preeclampsia poses significant risks to maternal and infant health globally.
  • Limited effective treatments exacerbate the impact of preeclampsia, especially in resource-limited areas.
  • The protein soluble FMS-like tyrosine kinase-1 (sFLT1) is implicated in preeclampsia pathogenesis.

Purpose of the Study:

  • To evaluate the efficacy of RNA interference (RNAi) therapy in a preeclampsia model.
  • To assess the potential of suppressing soluble FMS-like tyrosine kinase-1 (sFLT1) as a therapeutic strategy.

Main Methods:

  • Utilized a baboon model that mimics human preeclampsia.
  • Administered RNAi technology designed to target and reduce sFLT1 levels.
  • Monitored physiological parameters and sFLT1 concentrations.

Main Results:

  • Demonstrated successful suppression of the pathogenic sFLT1 protein using RNAi.
  • Observed positive outcomes in the baboon model, indicating therapeutic potential.
  • Validated RNAi as a viable approach for targeting sFLT1 in preeclampsia.

Conclusions:

  • RNAi technology shows promise for developing novel preeclampsia therapies.
  • Targeting sFLT1 with RNAi could offer a new treatment avenue.
  • This approach may provide accessible therapeutic options for high-burden regions.